Skip to main content
Equibles
OVID logo

OVID · Ovid Therapeutics Inc. · Holdings

Track OVID — free

Use OVID with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OVID.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.40 +0.23 (+10.60%)
Russell 2000 member Rebalance outlook locked
Market Cap
$423.80M
Shares
195.30M
Volume · Oct 20 3.64M Avg daily vol (3M) 1.62M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Use institutional holdings through the 13F API or MCP → See every holder of OVID: 13F, 13D and 13G, insiders and funds →
Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 133
Total Value: $396,048,692
Total Shares: 147,234,418
Showing 1–100 of 136 holdings by value · page 1 of 2

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 131 13F filers
Top Holder
14.1%
Sep 2023 → Jun 2026 · range 10.2% – 20.9%
of institutional value
Top 5
43.5%
Sep 2023 → Jun 2026 · range 43.5% – 60.4%
of institutional value
Top 10
67.9%
Sep 2023 → Jun 2026 · range 65.0% – 84.3%
of institutional value
HHI
594
Sep 2023 → Jun 2026 · range 573 – 927
Broadly held

Who Holds OVID

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 130 filers, like-for-like change +39.9%; actively managed books +17.5%; index-like books +257.1%.

Holder type Share Filers Change
Registered adviser 60.7% 63 +19.3%
Exempt adviser 0.9% 1 -50.6%
Adviser 4.9% 4 +4.4%
Bank 7.9% 12 +417.5%
Insurer 0.0% 1 new
Broker-dealer 0.0% 2 -16.9%
Benefit plan 0.0% 1 -97.9%
Non-US 0.1% 3 +15674.0%
Holding company 7.7% 7 +535.4%
Unknown 17.8% 36 +58.1%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Compared across CIK changes: JANUS HENDERSON GROUP PLC continues as Jupiter Topco LLC.

Conviction and Crowding

130 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Mar 31, 2026: 1
Holders above 5%
0
median weight 0.000%
Mar 31, 2026: 1
Crowding
41.7%
of shares outstanding, 93rd percentile
Mar 31, 2026: 56.9%
Private-fund advisers
40.9%
of shares outstanding
Institutional ownership
78.8%
84.7% of the estimated free float
Top 10 holders
68.0%
of 13F shares, Herfindahl 0.060
Active holders
+17.5%
like-for-like share change of active filers
5% stakes on record
10
0 13D, 10 13G (7 institutional, 3 passive, 0 exempt)
How long holders have held it value-weighted 6.1 quarters
Under 1 year 57.0% 1 to 3 years 31.8% 3 years or more 11.1% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $82,054 (1 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$1.97
estimated per share
Mar 31, 2026: $1.57
Quarter-end price
$2.69
implied by 13F values
Estimated gain or loss
+36.8%
price against the estimated cost
Estimated at a loss
0.085%
of costed 13F value

Estimated cost covers 76.1% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies OVID's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 CLYM Climb Bio, Inc. 10
2 IBIO iBio, Inc. 6
3 MGNX Macrogenics Inc 4
4 EQ Equillium, Inc. 5
5 AVTX Avalo Therapeutics, Inc. 9
6 PRLD Prelude Therapeutics Inc 4
7 TENX Tenax Therapeutics, Inc. 6
8 AMAN Amanat Acquisition Corp. 5
9 SPRB Spruce Biosciences, Inc. 5
10 ABOS Acumen Pharmaceuticals, Inc. 4

Shareholder Targets

13F filers that own its peers but not OVID, quarter ended Jun 30, 2026

Found through its holder-overlap peers: CLYM, IBIO, MGNX, EQ, AVTX, PRLD, TENX, AMAN, SPRB, ABOS, CLDX, ZURA, HLXC, MNPR, ASMB, AVR, OKUR, ARTV, LXEO, AMLX. 440 filers in all.

# Filer In peers
1 Commodore Capital LP Registered adviser, Concentrated $233,905,235 6 held
2 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $212,232,562 4 held
3 Kynam Capital Management, LP Registered adviser, Concentrated $210,937,819 2 held
4 TCG Crossover Management, LLC Unknown, Diversified active $186,721,286 3 held
5 Deep Track Capital, LP Adviser, Diversified active $176,078,608 2 held
6 GILEAD SCIENCES, INC. Unknown, Concentrated $136,770,405 1 held
7 Logos Global Management LP Registered adviser, Diversified active $114,947,178 6 held
8 Driehaus Capital Management LLC Registered adviser, Diversified active $113,565,980 5 held
9 Nantahala Capital Management, LLC Registered adviser, Diversified active $110,934,573 7 held
10 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $108,128,936 3 held

Fund Ownership of OVID by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 10.65% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.22% 2,377,111
Index ETFs 9.43% 18,420,738
Active ETFs 0.12% 224,950
Active funds 2.40% 4,686,076
Unclassified 0.05% 99,542
All registered funds 13.21% 25,808,417
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Holder type: Registered adviser 66 Exempt adviser 1 Adviser 4 Bank 12 Insurer 1 Broker-dealer 2 Benefit plan 1 Non-US 3 Holding company 7 Unknown 36
Showing 100 of 136
All Common Calls Puts
Export CSV
Holder Value (USD) % of 13F Shares Open
Jupiter Topco LLC $55,793,919 14.09% 20,741,234
EVENTIDE ASSET MANAGEMENT, LLC $31,774,928 8.02% 11,812,241
BlackRock, Inc. $29,115,159 7.35% 10,823,480
RA CAPITAL MANAGEMENT, L.P. $28,247,603 7.13% 10,500,968
Affinity Asset Advisors, LLC $27,288,871 6.89% 10,144,562
STATE STREET CORP $21,253,057 5.37% 7,900,765
VANGUARD CAPITAL MANAGEMENT LLC $20,874,706 5.27% 7,760,114
ADAR1 Capital Management, LLC $19,953,018 5.04% 7,417,479
Balyasny Asset Management L.P. $18,074,314 4.56% 6,719,076
ADAGE CAPITAL PARTNERS GP, L.L.C. $16,580,570 4.19% 6,163,781
FEDERATED HERMES, INC. $16,009,981 4.04% 5,951,666
BRAIDWELL LP $15,923,358 4.02% 5,919,464
GEODE CAPITAL MANAGEMENT, LLC $10,955,436 2.77% 4,072,653
SILVERARC CAPITAL MANAGEMENT, LLC $8,342,037 2.11% 3,101,129
STEMPOINT CAPITAL LP $6,502,491 1.64% 2,417,283
Ikarian Capital, LLC $6,105,503 1.54% 2,269,704
Point72 Asset Management, L.P. $5,234,005 1.32% 1,945,727
SPHERA FUNDS MANAGEMENT LTD. $3,639,570 0.92% 1,353,000
NORTHERN TRUST CORP $3,352,113 0.85% 1,246,139
VANGUARD FIDUCIARY TRUST CO $3,068,625 0.77% 1,140,753
Propel Bio Management, LLC $3,000,797 0.76% 1,115,538
Rosalind Advisors, Inc. $2,980,503 0.75% 1,107,994
VANGUARD PORTFOLIO MANAGEMENT LLC $2,773,236 0.70% 1,030,943
Sio Capital Management, LLC $2,704,348 0.68% 1,005,334
Ensign Peak Advisors, Inc $2,657,945 0.67% 988,084
Nuveen, LLC $2,402,853 0.61% 893,254
TWO SIGMA INVESTMENTS, LP $2,239,096 0.57% 832,378
WELLS FARGO & COMPANY/MN $2,222,493 0.56% 826,206
ORBIMED ADVISORS LLC $2,009,430 0.51% 747,000
BOOTHBAY FUND MANAGEMENT, LLC $1,984,569 0.50% 737,758
Saturn V Capital Management LP $1,783,631 0.45% 663,060
Ally Bridge Group (NY) LLC $1,680,069 0.42% 624,561
UBS Group AG $1,234,486 0.31% 458,917
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $1,194,472 0.30% 444,042
Bank of New York Mellon Corp $1,119,893 0.28% 416,318
BANK OF AMERICA CORP /DE/ $1,101,527 0.28% 409,490
DIMENSIONAL FUND ADVISORS LP $1,043,091 0.26% 387,767
GOLDMAN SACHS GROUP INC $894,940 0.23% 332,692
Informed Momentum Co LLC $698,407 0.18% 259,631
Atom Investors LP $677,438 0.17% 251,836
CIBC WORLD MARKET INC. $588,709 0.15% 218,851
Parkman Healthcare Partners LLC $532,477 0.13% 197,947
SEI INVESTMENTS CO $529,082 0.13% 196,685
CITIGROUP INC $513,945 0.13% 191,058
Invesco Ltd. $470,479 0.12% 174,900
RHUMBLINE ADVISERS $457,673 0.12% 170,139
AMERICAN CENTURY COMPANIES INC $455,637 0.12% 169,382
DEUTSCHE BANK AG\ $401,861 0.10% 149,391
Rafferty Asset Management, LLC $367,922 0.09% 136,774
Velan Capital Investment Management LP $349,700 0.09% 130,000
PRICE T ROWE ASSOCIATES INC /MD/ $338,200 0.09% 125,725
SUSQUEHANNA INTERNATIONAL GROUP, LLP $303,701 0.08% 112,900
RENAISSANCE TECHNOLOGIES LLC $283,795 0.07% 105,500
WELLINGTON MANAGEMENT GROUP LLP $278,146 0.07% 103,400
BRIDGEWAY CAPITAL MANAGEMENT, LLC $256,717 0.06% 95,434
Empowered Funds, LLC $245,419 0.06% 91,234
MetLife Investment Management, LLC $243,679 0.06% 90,587
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $231,602 0.06% 86,098
ALLIANCEBERNSTEIN L.P. $210,519 0.05% 78,260
SUSQUEHANNA INTERNATIONAL GROUP, LLP $198,791 0.05% 73,900
TWO SIGMA SECURITIES, LLC $192,300 0.05% 71,487
SUSQUEHANNA INTERNATIONAL GROUP, LLP $189,914 0.05% 70,600
Vanguard Global Advisers, LLC $189,717 0.05% 70,527
PROFUND ADVISORS LLC $187,490 0.05% 69,699
JPMORGAN CHASE & CO $170,766 0.04% 63,482
MORGAN STANLEY $153,111 0.04% 56,919
State of Wyoming $143,748 0.04% 53,438
LPL Financial LLC $134,769 0.03% 50,100
Police & Firemen's Retirement System of New Jersey $121,483 0.03% 45,161
MANUFACTURERS LIFE INSURANCE COMPANY, THE $110,047 0.03% 40,910
FMR LLC $104,936 0.03% 39,010
D. E. Shaw & Co., Inc. $99,199 0.03% 36,877
Verdad Advisers, LP $95,626 0.02% 35,549
NEW YORK STATE COMMON RETIREMENT FUND $95,226 0.02% 35,400
Schonfeld Strategic Advisors LLC $94,281 0.02% 35,049
XTX Topco Ltd $92,374 0.02% 34,340
BARCLAYS PLC $91,782 0.02% 34,120
MILLENNIUM MANAGEMENT LLC $86,873 0.02% 32,295
Spark Investment Management LLC $85,542 0.02% 31,800
Sovereign Financial Group, Inc. $80,700 0.02% 30,000
VOYA INVESTMENT MANAGEMENT LLC $78,757 0.02% 29,278
BLAIR WILLIAM & CO/IL $77,576 0.02% 28,839
INTECH INVESTMENT MANAGEMENT LLC $77,541 0.02% 28,826
Total Clarity Wealth Management, Inc. $73,735 0.02% 27,411
CITADEL ADVISORS LLC $71,016 0.02% 26,400
Abel Hall, LLC $70,962 0.02% 28,499
FIRST MANHATTAN CO. LLC. $69,940 0.02% 26,000
BNP PARIBAS ARBITRAGE, SA $64,226 0.02% 23,876
PRUDENTIAL FINANCIAL INC $62,125 0.02% 23,095
Stonepine Capital Management, LLC $57,297 0.01% 21,300
Creative Planning $56,484 0.01% 20,998
ProShare Advisors LLC $53,931 0.01% 20,049
Focus Partners Advisor Solutions, LLC $53,800 0.01% 20,000
VICTORY CAPITAL MANAGEMENT INC $52,046 0.01% 19,348
CITADEL ADVISORS LLC $51,917 0.01% 19,300
E Fund Management Co., Ltd. $51,879 0.01% 19,286
Benin Management CORP $51,110 0.01% 19,000
Squarepoint Ops LLC $50,940 0.01% 18,937
TLS Advisors LLC $50,728 0.01% 18,858
GROUP ONE TRADING LLC $50,203 0.01% 18,663

Showing the top 100 of 136 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1636651 CUSIP 690469101 13F (30d) 8 filings 8 filers Visit website Investor relations